Unity Biotechnology Faces Delisting Concerns
| Field | Detail |
|---|---|
| Company | Unity Biotechnology, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, compliance, regulatory
TL;DR
Unity Bio might get delisted - big trouble ahead.
AI Summary
Unity Biotechnology, Inc. filed an 8-K on June 20, 2025, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company, previously known as Cenexys, Inc. and Forge Inc., is incorporated in Delaware and headquartered in South San Francisco, California.
Why It Matters
This filing indicates potential issues with Unity Biotechnology's continued listing on an exchange, which could significantly impact its stock value and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's operations and stock value.
Key Numbers
- 001-38470 — Commission File Number (Identifies the company's SEC filings)
- 26-4726035 — IRS Employer Identification Number (Tax identification for the company)
Key Players & Entities
- Unity Biotechnology, Inc. (company) — Registrant
- Cenexys, Inc. (company) — Former Company Name
- Forge Inc (company) — Former Company Name
- June 18, 2025 (date) — Earliest event reported
- June 20, 2025 (date) — Filing Date
- 285 East Grand Ave. South San Francisco, CA 94080 (address) — Principal executive offices
FAQ
What specific listing rule or standard has Unity Biotechnology failed to satisfy?
The filing does not specify the exact rule or standard that Unity Biotechnology has failed to satisfy, only that a notice has been issued.
What is the expected timeline for the delisting process?
The filing does not provide a specific timeline for the delisting process.
What actions, if any, is Unity Biotechnology taking to address the delisting concerns?
The filing does not detail any specific actions Unity Biotechnology is taking to address the delisting concerns.
When was Unity Biotechnology previously known as Cenexys, Inc. and Forge Inc.?
Unity Biotechnology was formerly known as Cenexys, Inc. with a name change date of July 3, 2013, and formerly known as Forge Inc with a name change date of May 4, 2009.
What is the primary business of Unity Biotechnology, Inc.?
Unity Biotechnology, Inc. is in the Pharmaceutical Preparations industry, as indicated by its Standard Industrial Classification code [2834].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Unity Biotechnology, Inc..